Golden Green, Inc. Vir Biotechnology, Inc. Transaction History

Golden Green, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$30.97 - $54.03 $154,230 - $269,069	-4,980 Closed	0 $0
Q3 2021 Oct 08, 2021	SELL	$34.9 - $54.54 $80,758 - $126,205	-2,314 Reduced 31.72%	4,980 $217,000
Q2 2021 Jul 14, 2021	BUY	$38.75 - $51.0 $6,277 - $8,262	162 Added 2.27%	7,294 $345,000
Q1 2021 Apr 13, 2021	BUY	$26.34 - $83.07 $187,856 - $592,455	7,132 New	7,132 $366,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Golden Green, Inc., based on Form 13F filings with the SEC.

Stay updated on Golden Green, Inc. with notifications on news.